Hyperthyroidism due to secretion of human chorionic gonadotropin in a patient with metastatic choriocarcinoma

A 26-year-old pregnant woman presenting with repeated episodes of vaginal bleeding, weight loss, and shortness of breath was diagnosed with choriocarcinoma with metastases to both lungs. Chorionic gonadotropin levels (hCG) were >2.5 x 10(6)mU/mL. Consistent with hCG-induced subclinical hyperthyro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Arquivos brasileiros de endocrinologia e metabologia 2005-04, Vol.49 (2), p.319-322
Hauptverfasser: Meister, Ludimyla H F, Hauck, Patrícia R, Graf, Hans, Carvalho, Gisah A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 322
container_issue 2
container_start_page 319
container_title Arquivos brasileiros de endocrinologia e metabologia
container_volume 49
creator Meister, Ludimyla H F
Hauck, Patrícia R
Graf, Hans
Carvalho, Gisah A
description A 26-year-old pregnant woman presenting with repeated episodes of vaginal bleeding, weight loss, and shortness of breath was diagnosed with choriocarcinoma with metastases to both lungs. Chorionic gonadotropin levels (hCG) were >2.5 x 10(6)mU/mL. Consistent with hCG-induced subclinical hyperthyroidism, she had a suppressed TSH of 0.037 mU/L (0.49 - 4.67), a T4 of 18.1 microg/dL (4.9 - 10.7), and T3 of 136 ng/dL (45 - 137). Chemotherapy with a combined regimen with etoposide, methotrexate, and dactinomycine was started. The initial course was complicated by urosepsis with respiratory distress requiring endotracheal intubation for 3 days. She then improved rapidly, and her thyroid function tests were within normal limits by day 12. Six months later, after ten cycles of chemotherapy, the patient was in remission without signs of residual tumor or hCG-induced paraneoplastic activity.
doi_str_mv 10.1590/S0004-27302005000200022
format Article
fullrecord <record><control><sourceid>proquest_sciel</sourceid><recordid>TN_cdi_scielo_journals_S0004_27302005000200022</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><scielo_id>S0004_27302005000200022</scielo_id><sourcerecordid>68618208</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3142-5e719f6cc614faf79d6a7b5c00a7aea8fc4717e8fbc5103bc9ce9871181e4f5f3</originalsourceid><addsrcrecordid>eNp9UV1LwzAUDaK4Of0LmiffNpN-pX2UoU4Y-KA-l-z2xma0TU1SZP_ezBUVBCGX3I9z7oFzCbnibMHTgt08M8aSeSRiFjGWhiLaR3REpt-D41_5hJw5tw2IpCiiUzLhGc-TKEumpF3terS-3lmjK-1aWg1IvaEOwaLXpqNG0XpoZUehNjY0NNA308nKeGt63dHwJO2l19h5-qF9TVv00vnQgZED0oLuTCvPyYmSjcOL8Z-R1_u7l-Vqvn56eFzerucQ8ySapyh4oTKAjCdKKlFUmRSbFBiTQqLMFSSCC8zVBlLO4g0UgEUuOM85JipV8YwsDnsdaGxMuTWD7YJg-eVb-ce3QLg-EHpr3gd0vmy1A2wa2aEZXJnlwbGI5QEoDkCwxjmLquytbqXdlZyV-9P8I3E5SgybFqsf3niL-BNBWYlc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68618208</pqid></control><display><type>article</type><title>Hyperthyroidism due to secretion of human chorionic gonadotropin in a patient with metastatic choriocarcinoma</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>Meister, Ludimyla H F ; Hauck, Patrícia R ; Graf, Hans ; Carvalho, Gisah A</creator><creatorcontrib>Meister, Ludimyla H F ; Hauck, Patrícia R ; Graf, Hans ; Carvalho, Gisah A</creatorcontrib><description>A 26-year-old pregnant woman presenting with repeated episodes of vaginal bleeding, weight loss, and shortness of breath was diagnosed with choriocarcinoma with metastases to both lungs. Chorionic gonadotropin levels (hCG) were &gt;2.5 x 10(6)mU/mL. Consistent with hCG-induced subclinical hyperthyroidism, she had a suppressed TSH of 0.037 mU/L (0.49 - 4.67), a T4 of 18.1 microg/dL (4.9 - 10.7), and T3 of 136 ng/dL (45 - 137). Chemotherapy with a combined regimen with etoposide, methotrexate, and dactinomycine was started. The initial course was complicated by urosepsis with respiratory distress requiring endotracheal intubation for 3 days. She then improved rapidly, and her thyroid function tests were within normal limits by day 12. Six months later, after ten cycles of chemotherapy, the patient was in remission without signs of residual tumor or hCG-induced paraneoplastic activity.</description><identifier>ISSN: 0004-2730</identifier><identifier>ISSN: 1677-9487</identifier><identifier>EISSN: 0004-2730</identifier><identifier>DOI: 10.1590/S0004-27302005000200022</identifier><identifier>PMID: 16184264</identifier><language>eng</language><publisher>Brazil: Sociedade Brasileira de Endocrinologia e Metabologia</publisher><subject>Adult ; Choriocarcinoma - secondary ; Chorionic Gonadotropin - secretion ; ENDOCRINOLOGY &amp; METABOLISM ; Female ; Humans ; Hyperthyroidism - drug therapy ; Hyperthyroidism - etiology ; Lung Neoplasms - secondary ; Pregnancy ; Receptors, Thyrotropin - metabolism ; Thyroid Function Tests ; Uterine Neoplasms - pathology</subject><ispartof>Arquivos brasileiros de endocrinologia e metabologia, 2005-04, Vol.49 (2), p.319-322</ispartof><rights>This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3142-5e719f6cc614faf79d6a7b5c00a7aea8fc4717e8fbc5103bc9ce9871181e4f5f3</citedby><cites>FETCH-LOGICAL-c3142-5e719f6cc614faf79d6a7b5c00a7aea8fc4717e8fbc5103bc9ce9871181e4f5f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16184264$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Meister, Ludimyla H F</creatorcontrib><creatorcontrib>Hauck, Patrícia R</creatorcontrib><creatorcontrib>Graf, Hans</creatorcontrib><creatorcontrib>Carvalho, Gisah A</creatorcontrib><title>Hyperthyroidism due to secretion of human chorionic gonadotropin in a patient with metastatic choriocarcinoma</title><title>Arquivos brasileiros de endocrinologia e metabologia</title><addtitle>Arq Bras Endocrinol Metabol</addtitle><description>A 26-year-old pregnant woman presenting with repeated episodes of vaginal bleeding, weight loss, and shortness of breath was diagnosed with choriocarcinoma with metastases to both lungs. Chorionic gonadotropin levels (hCG) were &gt;2.5 x 10(6)mU/mL. Consistent with hCG-induced subclinical hyperthyroidism, she had a suppressed TSH of 0.037 mU/L (0.49 - 4.67), a T4 of 18.1 microg/dL (4.9 - 10.7), and T3 of 136 ng/dL (45 - 137). Chemotherapy with a combined regimen with etoposide, methotrexate, and dactinomycine was started. The initial course was complicated by urosepsis with respiratory distress requiring endotracheal intubation for 3 days. She then improved rapidly, and her thyroid function tests were within normal limits by day 12. Six months later, after ten cycles of chemotherapy, the patient was in remission without signs of residual tumor or hCG-induced paraneoplastic activity.</description><subject>Adult</subject><subject>Choriocarcinoma - secondary</subject><subject>Chorionic Gonadotropin - secretion</subject><subject>ENDOCRINOLOGY &amp; METABOLISM</subject><subject>Female</subject><subject>Humans</subject><subject>Hyperthyroidism - drug therapy</subject><subject>Hyperthyroidism - etiology</subject><subject>Lung Neoplasms - secondary</subject><subject>Pregnancy</subject><subject>Receptors, Thyrotropin - metabolism</subject><subject>Thyroid Function Tests</subject><subject>Uterine Neoplasms - pathology</subject><issn>0004-2730</issn><issn>1677-9487</issn><issn>0004-2730</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UV1LwzAUDaK4Of0LmiffNpN-pX2UoU4Y-KA-l-z2xma0TU1SZP_ezBUVBCGX3I9z7oFzCbnibMHTgt08M8aSeSRiFjGWhiLaR3REpt-D41_5hJw5tw2IpCiiUzLhGc-TKEumpF3terS-3lmjK-1aWg1IvaEOwaLXpqNG0XpoZUehNjY0NNA308nKeGt63dHwJO2l19h5-qF9TVv00vnQgZED0oLuTCvPyYmSjcOL8Z-R1_u7l-Vqvn56eFzerucQ8ySapyh4oTKAjCdKKlFUmRSbFBiTQqLMFSSCC8zVBlLO4g0UgEUuOM85JipV8YwsDnsdaGxMuTWD7YJg-eVb-ce3QLg-EHpr3gd0vmy1A2wa2aEZXJnlwbGI5QEoDkCwxjmLquytbqXdlZyV-9P8I3E5SgybFqsf3niL-BNBWYlc</recordid><startdate>20050401</startdate><enddate>20050401</enddate><creator>Meister, Ludimyla H F</creator><creator>Hauck, Patrícia R</creator><creator>Graf, Hans</creator><creator>Carvalho, Gisah A</creator><general>Sociedade Brasileira de Endocrinologia e Metabologia</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>GPN</scope></search><sort><creationdate>20050401</creationdate><title>Hyperthyroidism due to secretion of human chorionic gonadotropin in a patient with metastatic choriocarcinoma</title><author>Meister, Ludimyla H F ; Hauck, Patrícia R ; Graf, Hans ; Carvalho, Gisah A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3142-5e719f6cc614faf79d6a7b5c00a7aea8fc4717e8fbc5103bc9ce9871181e4f5f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Adult</topic><topic>Choriocarcinoma - secondary</topic><topic>Chorionic Gonadotropin - secretion</topic><topic>ENDOCRINOLOGY &amp; METABOLISM</topic><topic>Female</topic><topic>Humans</topic><topic>Hyperthyroidism - drug therapy</topic><topic>Hyperthyroidism - etiology</topic><topic>Lung Neoplasms - secondary</topic><topic>Pregnancy</topic><topic>Receptors, Thyrotropin - metabolism</topic><topic>Thyroid Function Tests</topic><topic>Uterine Neoplasms - pathology</topic><toplevel>online_resources</toplevel><creatorcontrib>Meister, Ludimyla H F</creatorcontrib><creatorcontrib>Hauck, Patrícia R</creatorcontrib><creatorcontrib>Graf, Hans</creatorcontrib><creatorcontrib>Carvalho, Gisah A</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>SciELO</collection><jtitle>Arquivos brasileiros de endocrinologia e metabologia</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Meister, Ludimyla H F</au><au>Hauck, Patrícia R</au><au>Graf, Hans</au><au>Carvalho, Gisah A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hyperthyroidism due to secretion of human chorionic gonadotropin in a patient with metastatic choriocarcinoma</atitle><jtitle>Arquivos brasileiros de endocrinologia e metabologia</jtitle><addtitle>Arq Bras Endocrinol Metabol</addtitle><date>2005-04-01</date><risdate>2005</risdate><volume>49</volume><issue>2</issue><spage>319</spage><epage>322</epage><pages>319-322</pages><issn>0004-2730</issn><issn>1677-9487</issn><eissn>0004-2730</eissn><abstract>A 26-year-old pregnant woman presenting with repeated episodes of vaginal bleeding, weight loss, and shortness of breath was diagnosed with choriocarcinoma with metastases to both lungs. Chorionic gonadotropin levels (hCG) were &gt;2.5 x 10(6)mU/mL. Consistent with hCG-induced subclinical hyperthyroidism, she had a suppressed TSH of 0.037 mU/L (0.49 - 4.67), a T4 of 18.1 microg/dL (4.9 - 10.7), and T3 of 136 ng/dL (45 - 137). Chemotherapy with a combined regimen with etoposide, methotrexate, and dactinomycine was started. The initial course was complicated by urosepsis with respiratory distress requiring endotracheal intubation for 3 days. She then improved rapidly, and her thyroid function tests were within normal limits by day 12. Six months later, after ten cycles of chemotherapy, the patient was in remission without signs of residual tumor or hCG-induced paraneoplastic activity.</abstract><cop>Brazil</cop><pub>Sociedade Brasileira de Endocrinologia e Metabologia</pub><pmid>16184264</pmid><doi>10.1590/S0004-27302005000200022</doi><tpages>4</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0004-2730
ispartof Arquivos brasileiros de endocrinologia e metabologia, 2005-04, Vol.49 (2), p.319-322
issn 0004-2730
1677-9487
0004-2730
language eng
recordid cdi_scielo_journals_S0004_27302005000200022
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Adult
Choriocarcinoma - secondary
Chorionic Gonadotropin - secretion
ENDOCRINOLOGY & METABOLISM
Female
Humans
Hyperthyroidism - drug therapy
Hyperthyroidism - etiology
Lung Neoplasms - secondary
Pregnancy
Receptors, Thyrotropin - metabolism
Thyroid Function Tests
Uterine Neoplasms - pathology
title Hyperthyroidism due to secretion of human chorionic gonadotropin in a patient with metastatic choriocarcinoma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T00%3A55%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_sciel&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hyperthyroidism%20due%20to%20secretion%20of%20human%20chorionic%20gonadotropin%20in%20a%20patient%20with%20metastatic%20choriocarcinoma&rft.jtitle=Arquivos%20brasileiros%20de%20endocrinologia%20e%20metabologia&rft.au=Meister,%20Ludimyla%20H%20F&rft.date=2005-04-01&rft.volume=49&rft.issue=2&rft.spage=319&rft.epage=322&rft.pages=319-322&rft.issn=0004-2730&rft.eissn=0004-2730&rft_id=info:doi/10.1590/S0004-27302005000200022&rft_dat=%3Cproquest_sciel%3E68618208%3C/proquest_sciel%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68618208&rft_id=info:pmid/16184264&rft_scielo_id=S0004_27302005000200022&rfr_iscdi=true